Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Aug 17, 2012 (14 years ago)

Major Oral Peroxide

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Stability data does not support expiration date: Stability data indicates the Carbamide Peroxide will degrade below acceptable levels within the 24-month expiration date printed on the packaging.

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

Major Oral Peroxide (Carbamide Peroxide 10%), 2 fl oz (60 mL), Distributed by: Major Pharmaceuticals 31778 Enterprise Drive, Livonia, MI 48150, NDC 0904-4062-03

Affected NDC 0904-4062-03

Compare with the code on your package — it is the most precise check available.

Drug: Carbamide

Recalling firm
Axcentria Pharmaceuticals LLC
NDC code
0904-4062-03
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-134-2013 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Carbamide recalls

See all
Class II · Moderate risk

CAREone

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

Ongoing Wrong potency / content Bell Pharmaceuticals, Inc NDC 72476-838-34 D-0688-2026
Class II · Moderate risk

meijer

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

Ongoing Wrong potency / content Bell Pharmaceuticals, Inc NDC 41250-835-33 D-0687-2026
Class II · Moderate risk

Foster & Thrive

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

Ongoing Wrong potency / content Bell Pharmaceuticals, Inc NDC 70677-1154-01 D-0686-2026
Class II · Moderate risk

Leader

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

Ongoing Wrong potency / content Bell Pharmaceuticals, Inc NDC 70000-0689-1 D-0685-2026
Class II · Moderate risk

Good Neighbor Pharmacy

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

Ongoing Wrong potency / content Bell Pharmaceuticals, Inc NDC 46122-556-05 D-0684-2026

Other recalls by Axcentria Pharmaceuticals LLC

All 2012 recalls
Class II · Moderate risk

Hemo-Stat Solution

Marketed without an Approved NDA/ANDA; product is being manufactured and distributed without a NDC number

Terminated Unapproved drug Axcentria Pharmaceuticals, LLC D-1434-2014
Class III · Low risk

Major brand Infants' Mapap

Labeling; labeled with incorrect EXP Date; Incorrect expiration date printed on the outer packaging. Package incorrectly states 5/2014 should correctly state 4/2014

Terminated Stability / shelf life Axcentria Pharmaceuticals LLC NDC 0904-5255-30 D-1441-2012